Company Financials
Pharvaris N.V. Financials
Euro
business
Pharvaris N.V. Company Profile
Main Stock Listing
FSX: 9EN
Market Capitalization €859.0 Million as of July 1, 2025
Market Cap History
Valuations Metrics as of Jul. 5, 2025
| Trailing PE | -6.09 |
| Forward PE | -5.17 |
| Price to Sales TTM | € |
| Price to Book MRQ | €3.65 |
| Enterprise to Revenue | |
| Enterprise to EBITDA | -3.44 |
Financial Reports as of Mar. 31, 2025
Financials
| Fiscal Year Ends | 2024-12-31 |
| Most Recent Quarter | 2025-03-31 |
| Profit Margin | 0.00% |
| Operating Margin | 0.00% |
| Return on Assets TTM | -31.88% |
| Return on Equity TTM | -52.20% |
Income Statement
| Revenue TTM | €0 |
| Revenue per Share TTM | €0.00 |
| Quarterly Revenue Growth | % |
| Gross Profit TTM | €0 |
| EBITDA | €-159,490,880 |
| Net Income to Common TTM | €-152,543,600 |
| Diluted EPS TTM | €-2.81 |
| Quarterly Earnings Growth YoY | % |
Balance Sheet
| Total Cash MRQ | €236,495,936 |
| Total Cash per Share MRQ | €4.34 |
| Total Debt MRQ | € |
| Total Debt to Equity MRQ | 0.33 |
| Current Ratio MRQ | 11.10 |
| Book Value per Share MRQ | €4.14 |
Cash Flow
| Operating Cash Flow TTM | €-134,369,984 |
| Levered Free Cash Flow TTM | €-79,651,896 |
9EN Stock Info as of Jul. 5, 2025
Stock Statistics
| Shares Outstanding | 54,379,491 |
| Float Shares | 21,230,528 |
| Avg 10 Volume | 84 |
| Avg 30 Volume | None |
| Shares Short | None |
| Short Ratio | |
| Short % of Shares | % |
| % Held by Insiders | 6.25% |
| % Held by Institutions | 89.49% |
Stock Price Summary
| Beta | -2.86 |
| Fifty Two Week Low | €10.20 |
| Fifty Two Week High | €22.80 |
| Fifty Two Week Change | -2.65% |
| Day 50 MA | €14.63 |
| Day 200 MA | €16.23 |
Dividends and Splits
| Forward Annual Dividend Rate | € |
| Forward Annual Dividend Yield | % |
| Trailing Annual Dividend Rate | €0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Dividend Date | |
| Ex Dividend Date | |
| Last Split Factor | |
| Last Split Date |